BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23803948)

  • 21. Analysis of Four Types of Leukemia Using Gene Ontology Term and Kyoto Encyclopedia of Genes and Genomes Pathway Enrichment Scores.
    Lu J; Zhang Y; Wang S; Bi Y; Huang T; Luo X; Cai YD
    Comb Chem High Throughput Screen; 2020; 23(4):295-303. PubMed ID: 30599106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
    Yang ZY; Huang H; Tang JH; Yu H; Wang YD; Xiang XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):28-31. PubMed ID: 16562670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant transformation by abl and BCR/ABL.
    Van Etten RA
    Cancer Treat Res; 1992; 63():167-92. PubMed ID: 1363357
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
    Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
    Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of KIR2DS4 and its variant KIR1D with leukemia.
    Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
    Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
    [No Abstract]   [Full Text] [Related]  

  • 26. Progress and Prospects in Pediatric Leukemia.
    Madhusoodhan PP; Carroll WL; Bhatla T
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias.
    Liang R; Chan VV; Chan TK; Chiu E; Todd D
    Acta Haematol; 1991; 85(2):71-5. PubMed ID: 1850943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
    Williams RT; Sherr CJ
    Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models for chronic myeloid leukemia and acute lymphoblastic leukemia.
    Groffen J; Voncken JW; van Schaick H; Heisterkamp N
    Leukemia; 1992; 6 Suppl 1():44-6. PubMed ID: 1548935
    [No Abstract]   [Full Text] [Related]  

  • 30. Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias.
    Schmitt MW; Pritchard JR; Leighow SM; Aminov BI; Beppu L; Kim DS; Hodgson JG; Rivera VM; Loeb LA; Radich JP
    Clin Cancer Res; 2018 Nov; 24(21):5321-5334. PubMed ID: 30042204
    [No Abstract]   [Full Text] [Related]  

  • 31. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
    Lemes A; Gómez Casares MT; de la Iglesia S; Matutes E; Molero MT
    Cancer Genet Cytogenet; 1999 Aug; 113(1):100-2. PubMed ID: 10459357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of point mutations in the aminopeptidase N gene by SSCP analysis and sequencing.
    Lendeckel U; Wex T; Arndt M; Frank K; Franke A; Ansorge S
    Hum Mutat; 1998; Suppl 1():S158-60. PubMed ID: 9452074
    [No Abstract]   [Full Text] [Related]  

  • 33. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 34. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.
    Jones D; Kamel-Reid S; Bahler D; Dong H; Elenitoba-Johnson K; Press R; Quigley N; Rothberg P; Sabath D; Viswanatha D; Weck K; Zehnder J
    J Mol Diagn; 2009 Jan; 11(1):4-11. PubMed ID: 19095773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects.
    Berger R; Chen SJ; Chen Z
    Cancer Genet Cytogenet; 1990 Feb; 44(2):143-52. PubMed ID: 2404570
    [No Abstract]   [Full Text] [Related]  

  • 36. Consistent genetic abnormalities in human cancers as targets for selective therapies.
    Clarkson BD
    Mt Sinai J Med; 1992 Oct; 59(5):400-4. PubMed ID: 1435835
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biogenesis of microRNAs and their role in the development and course of selected hematologic disorders].
    Grenda A; Budzyński M; Filip AA
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():174-85. PubMed ID: 23475494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Reardon DA; Hanson CA; Roth MS; Castle VP
    Cancer; 1994 Mar; 73(5):1526-32. PubMed ID: 8111722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes.
    Chen Z; Morgan R; Berger CS; Pearce-Birge L; Stone JF; Sandberg AA
    Cancer Genet Cytogenet; 1993 Oct; 70(2):103-7. PubMed ID: 8242587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
    Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.